Does celecoxib have an adverse effect on bone remodeling and ingrowth in humans?

Clinical Orthopaedics and Related Research

Volumn 452, Issue , 2006, Pages 200-204

  Hofmann, Aaron A ^a,b   Bloebaum, Roy D ^a,b   Koller, Karyn E ^a,b   Lahav, Amit ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b VASLCHSC   (United States)

^c Milford Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; TANTALUM; TETRACYCLINE; TITANIUM; PROSTAGLANDIN SYNTHASE INHIBITOR; PYRAZOLE DERIVATIVE; SULFONAMIDE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANALGESIA; BONE DEFECT; BONE GROWTH; BONE MINERAL; BONE REMODELING; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; IMPLANTATION; MALE; OSSIFICATION; PRIORITY JOURNAL; TOTAL KNEE REPLACEMENT; ARTICLE; DRUG EFFECT; KNEE ARTHROPLASTY;

ARTHROPLASTY, REPLACEMENT, KNEE; BONE REMODELING; CYCLOOXYGENASE INHIBITORS; HUMANS; PYRAZOLES; SULFONAMIDES;

EID: 33750631701     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000238838.18799.61     Document Type: Conference Paper

References (23)

1. Aickin M, Gensler H. Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods. Am J Public Health. 1996;86:726-729.
2. Bhattacharyya T, Smith RM. Cardiovascular risks of coxibs: the orthopaedic perspective. J Bone Joint Surg Am. 2005;87:245-246.
3. Bloebaum RD, Bachus KN, Jensen JW, Scott DF, Hofmann AA. Porous-coated metal-backed patellar components in total knee replacement. J Bone Joint Surg Am. 1998;80:518-528.
4. Bloebaum RD, Bachus KN, Momberger NG, Hofmann AA. Mineral apposition rates of human cancellous bone at the interface of porous coated implants. J Biomed Mater Res. 1994;28:537-544.
5. Bloebaum RD, Merrell M, Gustke K, Simmons M. Retrieval analysis of a hydroxyapatite-coated hip prosthesis. Clin Orthop Relat Res. 1991;267:97-102.
6. Bloebaum RD, Mihalopoulus NL, Jensen JW, Dorr LD. Postmortem analysis of bone growth into porous-coated acetabular components. J Bone Joint Surg Am. 1997;79:1013-1022.
7. Bobyn JD, Poggie RA, Krygier JJ, Lewallen DG, Hanssen AD, Lewis RJ, Unger AS, O'Keefe TJ, Christie MJ, Nasser S, Wood JE, Stulberg SD, Tanzer M. Clinical validation of a structural porous tantalum biomaterial for adult reconstruction. J Bone Joint Surg Am. 2004;86(Suppl 2):123-129.
8. Dahners LE, Mullis BH. Effects of nonsteroidal anti-inflammatory drugs on bone formation and soft-tissue healing. J Am Acad Orthop Surg. 2004;12:139-143.
9. Frost HM. The regional acceleratory phenomenon: a review. Henry Ford Hosp Med J. 1983;31:3-9.
10. Frost HM, Villanueva AR, Roth H, Stanisavljevic S. Tetracycline bone labeling. J New Drugs. 1961;206-216.
11. Gerstenfeld LC, Thiede M, Seibert K, Mielke C, Phippard D, Svagr B, Cullinane D, Einhorn TA. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J Orthop Res. 2003;21:670-675.
12. Goodman SB, Ma T, Mitsunaga L, Miyanishi K, Genovese MC, Smith RL. Temporal effects of a COX-2-selective NSAID on bone ingrowth. J Biomed Mater Res A. 2005;72:279-287.
13. Hofmann AA, Bachus KN, Bloebaum RD. Comparative study of human cancellous bone remodeling to titanium and hydroxyapatite coated implants. J Arthroplasty. 1993;8:157-166.
14. Hofmann AA, Bloebaum RD, Bachus KN. Progression of human bone ingrowth into porous-coated implants. Acta Orthop Scand. 1997;68:161-166.
15. Mallory TH, Lombardi AV Jr, Fada RA, Dodds KL. Anesthesia options: choices and caveats. Orthopedics. 2000;23:919-920.
16. Mallory TH, Lombardi AV Jr, Fada RA, Dodds KL, Adams JB. Pain management for joint arthroplasty: preemptive analgesia. J Arthroplasty. 2002;17:129-133.
17. Reuben SS, Ekman EF. The effect of cyclooxygenase-2 inhibition on analgesia and spinal fusion. J Bone Joint Surg Am. 2005;87:536-542.
18. Seidenberg AB, An YH. Is there an inhibitory effect of COX-2 inhibitors on bone healing? Pharmacol Res. 2004;50:151-156.
19. Straube S, Derry S, McQuay HJ, Moore RA. Effect of preoperative Cox-II-selective NSAIDs (coxibs) on postoperative outcomes: a systematic review of randomized studies. Acta Anaesthesiol Scand. 2005;49:601-613.
20. Trancik T, Mills W, Vinson N. The effect of indomethacin, aspirin, and ibuprofen on bone ingrowth into a porous-coated implant. Clin Orthop Relat Res. 1989;249:113-121.
21. Williams-Russo P, Sharrock NE, Haas SB, Insall J, Windsor RE, Laskin RS, Ranawat CS, Go G, Ganz SB. Randomized trial of epidural versus general anesthesia: outcomes after primary total knee replacement. Clin Orthop Relat Res. 1996;331:199-208.
22. Willie B, Bloebaum R, Bireley W, Bachus K, Hofmann A. Determining relevance of a weight-bearing ovine model for bone ingrowth assessment. J Biomed Mater Res Part A. 2004;69:567-576.
23. Wright S. Adjusted p-values for simultaneous inference. Biometrics. 1992;48:1005-1013.